---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293641852.md"
description: "Gentherm shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance with its midpoint above estimates. Also, the company approved a new $400 million stock buyback program."
datetime: "2026-07-23T15:19:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293641852.md)
  - [en](https://longbridge.com/en/news/293641852.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293641852.md)
---

# 

Gentherm shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance with its midpoint above estimates. Also, the company approved a new $400 million stock buyback program.

### Related Stocks

- [THRM.US](https://longbridge.com/en/quote/THRM.US.md)

## Related News & Research

- [Segall Bryant & Hamill LLC Decreases Stock Holdings in Gentherm Inc $THRM](https://longbridge.com/en/news/294581079.md)
- [Top Executive Makes Notable Move in Gentherm Stock](https://longbridge.com/en/news/294458555.md)
- [Gentherm Q2 adjusted EBITDA beats estimates, sets $400 million buyback](https://longbridge.com/en/news/293595526.md)
- [THRM: Record revenue, raised guidance, new $400M buyback, and medical acquisition highlight the quarter](https://longbridge.com/en/news/293595072.md)
- [Gentherm Medical wins FDA clearance for ThermAffyx patient safety system](https://longbridge.com/en/news/293249176.md)